Cargando…

Beyond Chemotherapies: Recent Strategies in Breast Cancer Treatment

SIMPLE SUMMARY: Breast cancer remains the most frequent women cancer worldwide. The current policy of care for this cancer tends rather at therapeutic de-escalation, with therapies that evolve toward more targeted and more personalized treatments. Personalized medicine requires clinical, but also mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foulon, Arthur, Theret, Pierrick, Rodat-Despoix, Lise, Kischel, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565588/ https://www.ncbi.nlm.nih.gov/pubmed/32947780 http://dx.doi.org/10.3390/cancers12092634

Ejemplares similares

Store-Independent Calcium Entry and Related Signaling Pathways in Breast Cancer
por: Chamlali, Mohamed, et al.
Publicado: (2021)

Inositol (1,4,5)-Trisphosphate Receptors in Invasive Breast Cancer: A New Prognostic Tool?
por: Foulon, Arthur, et al.
Publicado: (2022)

Ion Channels: New Actors Playing in Chemotherapeutic Resistance
por: Kischel, Philippe, et al.
Publicado: (2019)

Downregulation of type 3 inositol (1,4,5)-trisphosphate receptor decreases breast cancer cell migration through an oscillatory Ca(2+) signal
por: Mound, Abdallah, et al.
Publicado: (2017)

Orai3 Calcium Channel Regulates Breast Cancer Cell Migration through Calcium-Dependent and -Independent Mechanisms
por: Chamlali, Mohamed, et al.
Publicado: (2021)

A Single Amino Acid Residue Constitutes the Third Dimerization Domain Essential for the Assembly and Function of the Tetrameric Polycystin-2 (TRPP2) Channel
por: Feng, Shuang, et al.
Publicado: (2011)

Efficacy and aesthetic outcomes for quilting sutures in the prevention of seroma after mastectomy
por: Foulon, Arthur, et al.
Publicado: (2023)

Mechanosensor Channels in Mammalian Somatosensory Neurons
por: Raoux, Matthieu, et al.
Publicado: (2007)

NGF Inhibits M/KCNQ Currents and Selectively Alters Neuronal Excitability in Subsets of Sympathetic Neurons Depending on their M/KCNQ Current Background
por: Jia, Zhanfeng, et al.
Publicado: (2008)

Oral cancer treatment: developments in chemotherapy and beyond
por: O'Neill, V J, et al.
Publicado: (2002)

Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment
por: Cai, Fengfeng, et al.
Publicado: (2019)

Recent Developments in Combination Chemotherapy for Colorectal and Breast Cancers with Topoisomerase Inhibitors
por: Jang, Jung Yoon, et al.
Publicado: (2023)

Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer
por: Lorusso, Vito, et al.
Publicado: (2020)

Recent advances in therapeutic strategies for triple-negative breast cancer
por: Li, Yun, et al.
Publicado: (2022)

Recent advances in targeted strategies for triple-negative breast cancer
por: Zhu, Shuangli, et al.
Publicado: (2023)

Treatment Strategies for Residual Disease following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022)

Recent advances in systemic therapy. Advances in adjuvant systemic chemotherapy of early breast cancer
por: López-Tarruella, Sara, et al.
Publicado: (2009)

Recent advances in the medical treatment of breast cancer
por: Vorobiof, Daniel A.
Publicado: (2016)

Chemotherapy Treatment Considerations in Metastatic Breast Cancer
por: Hanna, Kirollos, et al.
Publicado: (2021)

PARP Inhibitors in the Treatment of Early Breast Cancer: The Step Beyond?
por: Gonçalves, Anthony, et al.
Publicado: (2020)

Recent Developments of Systemic Chemotherapy for Gastric Cancer
por: Arai, Hiroyuki, et al.
Publicado: (2020)

Recent developments in topoisomerase-targeted cancer chemotherapy
por: Hevener, KirkE., et al.
Publicado: (2018)

Recent progress in nanomedicine for enhanced cancer chemotherapy
por: Wei, Guoqing, et al.
Publicado: (2021)

The Evolution and Recent Trends in Acoustic Targeting of Encapsulated Drugs to Solid Tumors: Strategies beyond Sonoporation
por: Honari, Arvin, et al.
Publicado: (2023)

Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment
por: Nader-Marta, Guilherme, et al.
Publicado: (2023)

Recent Advances in Chemotherapy
Publicado: (1939)

Recent Advances in Chemotherapy
Publicado: (1951)

Recent Advances in Chemotherapy
Publicado: (1950)

Recent advances in peptide-based therapeutic strategies for breast cancer treatment
por: Li, Ling, et al.
Publicado: (2023)

A polycystin-2 (TRPP2) dimerization domain essential for the function of heteromeric polycystin complexes
por: Giamarchi, Aurélie, et al.
Publicado: (2010)

Recent Advances in the Neoadjuvant Treatment of Breast Cancer
por: Rubovszky, Gábor, et al.
Publicado: (2017)

Triple-negative breast cancer: recent treatment advances
por: Bergin, Alice R T, et al.
Publicado: (2019)

Breast Cancer: Exploring the Facts and Holistic Needs during and beyond Treatment
por: Ng, Zhi Xuan, et al.
Publicado: (2017)

Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
por: Agostinetto, Elisa, et al.
Publicado: (2022)

Topoisomerases and cancer chemotherapy: recent advances and unanswered questions
por: Bjornsti, Mary-Ann, et al.
Publicado: (2019)

Lipoprotein(a) in patients with breast cancer after chemotherapy: exploring potential strategies for cardioprotection
por: Wang, Ziqing, et al.
Publicado: (2023)

The Utilization of the Immune System in Lung Cancer Treatment: Beyond Chemotherapy
por: Chan, Carmen W. H., et al.
Publicado: (2016)

Recent Advances in Chemotherapy (Churchill)
Publicado: (1954)

Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer
por: Hou, Sicong, et al.
Publicado: (2021)

Aromatase inhibitor strategies in metastatic breast cancer
por: McArthur, Heather L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gf54euh36s1p6ke255m189h1vq